Hormone Replacement Therapy Market
Global Hormone Replacement Therapy Market Size, Share & Trends Analysis Report by Therapy Type (Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement), by Route of Administration (Oral, Parenteral, Other Routes of Administration), by Disease (Menopause, Hypothyroidism, Hypogonadism, Growth Hormone Deficiency, Others), Forecast Period (2020-2026)
The global hormone replacement therapy market is projected to grow at a considerable CAGR of around 7% during the forecast period (2020-2026). Hormonal imbalances lead to weight gain, fatigue, memory decline, low libido, and muscle loss. According to the American Thyroid Association, an estimated 20 million Americans have some type of thyroid disease in which approximately 60% of the population are unaware of their thyroid disease. The high prevalence of hormonal imbalance disorders such as menopause, hyperthyroidism, and so on is a key factor contributing to the growth of the hormone replacement therapy market across the globe.
As per the United Nations, the global population in 2019 was 7.7 billion, out of which, around 4 billion are females. Out of this, around 50% is the target population in the age range of 15 to 50 years. It is equivalent to around 1.9 billion of the female population. This population is expected to increase to around 2.1 billion by 2025. Hormonal imbalance disorders occur with the growing older age. Therefore, the growing geriatric female population is expected to create the demand for hormone therapy replacement market. However, the high cost of hormone replacement therapies and shortage of products due to weak product pipeline are some factors that may restrain the growth of the global hormone replacement therapy market.
Segmental Outlook
The hormone replacement therapy market is segmented on the basis of therapy type, route of administration, and disease. Based on the therapy type, the market is segmented into estrogen hormone replacement, growth hormone replacement, thyroid hormone replacement, and testosterone replacement. Estrogen replacement therapy is anticipated to hold considerable market share based on the therapy type. Women highly opt for this therapy during post-menopause to maintain their hormonal balance. The huge adoption of this therapy is anticipated to drive the growth of this market segment. Based on the route of administration, the market into oral, parenteral, and other routes of administration. Based on disease type, the market is segmented into menopause, hypothyroidism, hypogonadism, growth hormone deficiency, and others.
Parenteral to be considerable segment based on Route of administration
Parenteral is the highly preferred route of administration for the treatment of hormone replacement therapy. Improved adherence, immediate action, and controlled drug delivery by administrators are the key advantages that the parenteral route of administration offers. The benefits offered by the parenteral route of administration is a key factor contributing to the high market share of the market segment.
Global Hormone Replacement Therapy Market Share by Route of Administration, 2019 (%)
Regional Outlook
The global hormone replacement therapy market is further segmented on the basis of geography including North America, Europe, Asia-Pacific, and Rest of the World. North America is anticipated to hold a considerable market share during the forecast period. Various factors such as the increasing prevalence of menopause, raising the number of hormone replacement procedures, and the presence of major market players generating a large portion of sales from the US are the key factor contributing towards the high market share of the region. In addition, the region has well-developed healthcare infrastructure and is experiencing increased healthcare expenditure that further boosts the regional growth of the market in a particular region. Additionally, the market players present in the US are emphasizing on the R&D of novel therapies for enabling better outcomes of hormone replacement therapy.
Global Hormone Replacement Therapy Market Growth, by Region 2020-2026
Asia-Pacific to exhibit considerable growth during the forecast period 2020-2026
The rapidly evolving healthcare infrastructure, growing per capita healthcare expenditure, along with the presence of huge targeted patient pool is anticipated to be the key factors driving the growth of the hormone replacement therapy market in the Asia-Pacific region. Furthermore, the government of the region is emphasizing on conducting programs for raising awareness regarding these therapies to circumvent the side effects of hormonal imbalance disorders is also contributing to market growth. However, the presence of underdeveloped healthcare infrastructure may restrain the growth of the hormone replacement therapy market in some slow growth economies of the Asia-Pacific region.
Market Players Outlook
The major players of the hormone replacement therapy market include Abbott Laboratories, Inc. Pfizer Inc., Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Hisamitsu Pharmaceutical Co. Inc., Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, Fuji Pharma Co., Ltd., Cyndea Pharma, Dwarkesh Pharmaceuticals Pvt. Ltd., and so on. These players are actively adopting different growth strategies such as new product launch, partnerships, collaboration, and mergers and acquisition among others to remain competitive in the market place.
The Report Covers
- Market value data analysis of 2019 and forecast to 2026.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global hormone replacement therapy market. Based on the availability of data, information related to the products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Bayer AG
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Abbott Laboratories, Inc.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Novartis AG
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Pfizer, Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Merck KGaA
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.1. Opportunities
5. Market Segmentation
5.1. Global Hormone Replacement Therapy Market by Therapy Type
5.1.1. Estrogen Hormone Replacement
5.1.2. Growth Hormone Replacement
5.1.3. Thyroid Hormone Replacement
5.1.4. Testosterone Replacement
5.2. Global Hormone Replacement Therapy Market by Route of Administration
5.2.1. Oral
5.2.2. Parenteral
5.2.3. Other Routes of Administration
5.3. Global Hormone Replacement Therapy Market by Disease
5.3.1. Menopause
5.3.2. Hypogonadism
5.3.3. Hypothyroidism
5.3.4. Growth Hormone Deficiency
5.3.5. Others
6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. AbbVie, Inc.
7.3. Allergan PLC
7.4. Bayer AG
7.5. Bristol Myers Squibb Co.
7.6. Cyndea Pharma, S.L.
7.7. Dwarkesh Pharmaceuticals Pvt., Ltd.
7.8. Eli Lilly and Co.
7.9. F. Hoffmann-La Roche, Ltd.
7.10. Fuji Pharma Co., Ltd.
7.11. Hisamitsu Pharmaceutical Co., Inc.
7.12. Merck KGaA
7.13. Mylan N.V.
7.14. Novartis AG
7.15. Novo Nordisk A/S
7.16. Pfizer, Inc.
7.17. TherapeuticsMD, Inc.
7.18. Titan Pharmaceuticals, Inc.
1. GLOBAL HORMONE REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
2. GLOBAL ESTROGEN HORMONE REPLACEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
3. GLOBAL GROWTH HORMONE REPLACEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
4. GLOBAL THYROID HORMONE REPLACEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
5. GLOBAL TESTOSTERONE REPLACEMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
6. GLOBAL OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
7. GLOBAL HORMONE REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
8. GLOBAL ORAL MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
9. GLOBAL PARENTERAL MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
10. GLOBAL OTHER ROUTES OF ADMINISTRATION MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
11. GLOBAL HORMONE REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DISEASE, 2019-2026 ($ MILLION)
12. GLOBAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
13. GLOBAL HYPOGONADISM MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
14. GLOBAL HYPOTHYROIDISM MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
15. GLOBAL GROWTH HORMONE DEFICIENCY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
16. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
17. NORTH AMERICAN HORMONE REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
18. NORTH AMERICAN HORMONE REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY THERAPY TYPE, 2019-2026 ($ MILLION)
19. NORTH AMERICAN HORMONE REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
20. NORTH AMERICAN HORMONE REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DISEASE, 2019-2026 ($ MILLION)
21. EUROPEAN HORMONE REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
22. EUROPEAN HORMONE REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY THERAPY TYPE, 2019-2026 ($ MILLION)
23. EUROPEAN HORMONE REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
24. EUROPEAN HORMONE REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DISEASE, 2019-2026 ($ MILLION)
25. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
26. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY THERAPY TYPE, 2019-2026 ($ MILLION)
27. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
28. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DISEASE, 2019-2026 ($ MILLION)
29. REST OF THE WORLD HORMONE REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY THERAPY TYPE, 2019-2026 ($ MILLION)
30. REST OF THE WORLD HORMONE REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
31. REST OF THE WORLD HORMONE REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY DISEASE, 2019-2026 ($ MILLION)
1. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SHARE BY THERAPY TYPE, 2019 VS 2026 (%)
2. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SHARE BY ROUTE OF ADMINISTRATION, 2019 VS 2026 (%)
3. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SHARE BY DISEASE, 2019 VS 2026 (%)
4. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
5. THE US HORMONE REPLACEMENT THERAPY MARKET SIZE, 2019-2026 ($ MILLION)
6. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2019-2026 ($ MILLION)
7. UK HORMONE REPLACEMENT THERAPY MARKET SIZE, 2019-2026 ($ MILLION)
8. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, 2019-2026 ($ MILLION)
9. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, 2019-2026 ($ MILLION)
10. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, 2019-2026 ($ MILLION)
11. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, 2019-2026 ($ MILLION)
12. ROE HORMONE REPLACEMENT THERAPY MARKET SIZE, 2019-2026 ($ MILLION)
13. INDIA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2019-2026 ($ MILLION)
14. CHINA HORMONE REPLACEMENT THERAPY MARKET SIZE, 2019-2026 ($ MILLION)
15. JAPAN HORMONE REPLACEMENT THERAPY MARKET SIZE, 2019-2026 ($ MILLION)
16. REST OF ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET SIZE, 2019-2026 ($ MILLION)
17. REST OF THE WORLD HORMONE REPLACEMENT THERAPY MARKET SIZE, 2019-2026 ($ MILLION)
